Skip to main content

Table 2 Association between obstetric complications and first-episode psychosis

From: The impact of peri-natal stress on psychosis risk: results from the Bo-FEP incidence study

Health status of the mothers

Cases

Controls

n (%)

42 (100.0)

26 (100.0)

 First child

29 (69.0)

15 (57.7)

 Second child

8 (19.0)

8 (30.8)

 Third or further child

5 (11.9)

3 (11.5)

Mean age of the parents at cases’ births (SD)

 Mothers’ age

26.88 (5.4)

28.46 (5.3)

 Fathers’ age

31.08 (6.06)

31.81 (5.7)

Mean age of the mothers at the interview (SD)

58.57 (9.5)

58.96 (5.4)

Maternal disorders history, n (%)

42 (100.0)

26 (100.0)

 Negative***

20 (46.6)

24 (92.3)

 Positive***

22 (52.4)

2 (7.7)

 Endocrine-Metabolic disorders

5 (11.9)

0 (.0)

 Cardio-vascular disorders

4 (9.5)

0 (0.0)

 Respiratory disorders

2 (4.8)

0 (0.0)

 Neurological disorders

1 (2.4)

0 (0.0)

 Gynaecological disorders *

9 (21.4)

1 (3.8)

 Other

9 (21.4)

2 (7.7)

Pathological obstetric history, n (%)

42 (100.0)

26 (100.0)

 Not applicable

29 (69.0)

14 (53.8)

 Negative

10 (23.8)

10 (38.5)

 Positive

3 (7.1)

2 (7.7)

OCs, n (%)

42 (100.0)

26 (100.0)

 Present

27 (65.9)

20 (76.9)

 Absent

14(34.1)

6 (23.1)

Negatives memories (e.g. trauma), n (%)

42 (100.0)

26 (100.0)

 No***

18 (42.9)

24 (92.3)

 Yes***

24 (57.1)

2 (7.7)

Use of drugs-alcohol-substances in pregnancy

 Not-users

24 (57.1)

14 (53.8)

 Users

18 (42.9)

12 (46.2)

Alcohol during pregnancy, n (%)

15 (35.7)

11 (42.2)

 Monthly or less

3 (7.1)

1 (3.8)

 2–3 time/month

5 (11.9)

1 (3.8)

 2–3 times/week

5 (11.9

8 (30.8)

 Every day

2 (4.8)

1 (3.8)

Smoking during pregnancy, n (%)

7 (15.8)

3 (11.5)

 6–9 sigarettes/die

6 (14.3)

2 (7.7)

 10–20 sigarettes/die

1 (2.4)

1 (3.8)

 Other smokers at home

18 (43.9)

14 (56.0)

 Other Substances during pregnancy, n (%)

0 (0.0)

0 (0.0)

Medicinal drugs during pregnancy, n (%)

35 (100.0)

24 (100.0)

 Yes*

12 (34.3)

3 (12.5)

 No*

23 (65.7)

21 (87.5)

 Anti-inflammatory drugs**

7 (20.6)

0 (0.0)

  1. *p < 0.1 e > 0.05; **p < 0.05 e > 0.001; ***p < o = 0.001